DISTEK INC.

Company Snapshot

Founded: 1976
Entity Type: Private
Region: U.S.
Headquarter: New Jersey, U.S.
Key Geographics: U.S.
Corporate Address: 121 North Center Drive, North Brunswick, New Jersey 08902 U.S. Tel. +1-732-422-7585 www.distekinc.com

Company Overview

Distek Inc. is a New Jersey-based laboratory testing equipment manufacturer. The company was established in 1976 in North Brunswick, N.J. The company offers validation and qualification services in the pharmaceutical and biotechnology sectors. Products provided by the company include water bath and bathless dissolution testing, programmable syringe pump dissolution, in-situ fiber optic UV dissolution testing, waters HPLC (High-Performance Liquid Chromatography) dissolution testing, and dissolution auto sampling. The company works with generic and biosimilar drug manufacturers, CROs, CMOs, nutraceuticals, government agencies, and universities.

In its bioprocessing portfolio, the company provides a bioprocess control station and single-use bioreactor. The bioprocess control station, BIOne-1250, is a bioreactor for both mammalian and microbial models. The BIOne single-use bioreactor is used for cell culture and recombinant protein production.

DISTEK INC. In Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

BCC Research Market Analyst says global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029 at a CAGR of...

Single-use Technologies for Biopharmaceuticals: Global Markets

BCC Research Market Report for Single-use Biopharmaceutical’s technologies. Get market applications, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives and anticancer drugs....

Single-use Technologies for Biopharmaceuticals: Global Markets

The global single-use technology in the biopharmaceutical market should reach $5.9 billion by 2024 from $3.5 billion in 2019 at a compound annual growth rate of 11.3% for the period of 2019 to 2024.

Company's Business Segments

  • Product : Pharmaceuticals Apparatus, UV Fiber Optic Dissolution, Bioprocessing Equipments, Others
  • Service : Validation and Qualification, Compliance Support, Distekniques, Others

Applications/End User Industries

  • Pharmaceuticals
  • Biotechnology
  • Government Agencies and Universities
AI Sentiment